Keyphrases
Saliva
100%
Pain Patients
100%
Endocannabinoid Tone
100%
Chronic Orofacial Pain
100%
Neurovascular Unit
42%
2-Arachidonoylglycerol (2-AG)
42%
Orofacial Pain
42%
Salivary Levels
42%
N-oleoylethanolamine
42%
Neuropathic Pain
28%
Arachidonic Acid
28%
Endocannabinoids
28%
Pain Types
28%
Migraine Pain
28%
Pathological Process
14%
Physiological Processes
14%
No Significant Difference
14%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
14%
Endocannabinoid System
14%
Prognostic Implications
14%
Endogenous Precursors
14%
Pain Mechanisms
14%
Pain Sensation
14%
Change Detection
14%
Anandamide
14%
Pain Intensity
14%
Therapeutic Implications
14%
Free Control
14%
Breakdown Products
14%
Musculoskeletal Pain
14%
Endocannabinoid Levels
14%
Pain Modulation
14%
Palmitoylethanolamine
14%
Pain Generation
14%
Neuroscience
Endocannabinoid
100%
2-Arachidonoylglycerol
75%
Neuropathic Pain
50%
Arachidonic Acid
50%
Migraine
50%
Liquid Chromatography-Mass Spectrometry
25%
Anandamide
25%
Endocannabinoid System
25%
Medicine and Dentistry
Endocannabinoid
100%
Orofacial Pain
100%
2 Arachidonoylglycerol
30%
Neuropathic Pain
20%
Migraine
20%
Arachidonic Acid
20%
Diagnosis
10%
Pathological Process
10%
Precursor
10%
Endocannabinoid System
10%
Sensation
10%
Anandamide
10%
Liquid Chromatography-Mass Spectrometry
10%
Musculoskeletal Pain
10%